TLR9, the first identified DNA-sensing receptor expressed in innate immune cells, is critical in mediating the accumulation, antigen uptake, lymph node migration, and maturation of tumor DCs after chemotherapy, as indicated by TLR9-deficient mice failing to present effective antitumor immune responses [87]. This evidence concerns the gene TLR9 and neoplasm.